Lombard Odier Asset Management (USA) Corp - SILENCE THERAPEUTICS PLC ownership

SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 7 filers reported holding SILENCE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (USA) Corp ownership history of SILENCE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$33,740,000
+80.7%
4,057,932
-1.5%
0.76%
+91.2%
Q2 2023$18,668,445
-9.8%
4,120,416
+4.1%
0.40%
-13.0%
Q1 2023$20,689,170
-59.1%
3,959,101
+2.2%
0.46%
-64.8%
Q4 2022$50,594,057
+41.6%
3,875,734
-0.5%
1.29%
+24.7%
Q3 2022$35,721,000
-6.4%
3,896,595
+3.5%
1.04%
-29.3%
Q2 2022$38,166,000
-31.5%
3,766,369
+3.7%
1.47%
-27.9%
Q1 2022$55,692,000
-32.9%
3,632,234
+4.6%
2.04%
-37.2%
Q4 2021$82,959,000
+678.7%
3,472,521
+480.6%
3.24%
+593.4%
Q3 2021$10,653,000
-50.7%
598,141
-34.5%
0.47%
-45.6%
Q2 2021$21,608,000
-11.5%
913,134
-23.8%
0.86%
-4.5%
Q1 2021$24,425,000
+140.3%
1,198,141
+121.9%
0.90%
+84.0%
Q4 2020$10,166,000
+25.5%
540,0000.0%0.49%
-7.2%
Q3 2020$8,103,000540,0000.53%
Other shareholders
SILENCE THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 634,270$7,516,00031.70%
Lombard Odier Asset Management (USA) Corp 3,766,369$38,166,0001.47%
GREAT POINT PARTNERS LLC 401,449$4,757,0001.14%
Frazier Life Sciences Management, L.P. 881,173$10,442,0000.98%
Deep Track Capital, LP 951,580$11,276,0000.74%
BVF INC/IL 666,666$7,900,0000.38%
Parkman Healthcare Partners LLC 26,250$311,0000.12%
CANTOR FITZGERALD, L. P. 211,460$2,506,0000.05%
AXA S.A. 1,283,332$15,207,7420.03%
WS MANAGEMENT LLLP 25,000$296,0000.02%
View complete list of SILENCE THERAPEUTICS PLC shareholders